Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Immucor initiated a recall to communicate the release of a software upgrade on the galileo neo. this software upgrade includes modifications to the capture-r ready screen and capture-r ready id extend i and extend ii assays to improve assay performance.